GLP-1 Injections Explained: How the Pens Work and What to Expect

• Explains the pen as a device, not just the medicine inside it
• Covers injection sites, rotation and why the same spot causes problems
• Answers the pain and needle size questions honestly rather than reassuringly
• Sets out storage, travel and the situations where a pen should not be used

Almost everything written about GLP-1 medicines is about the medicine. Very little is about the object you will be holding on a Sunday morning, which is a small plastic pen with a needle you can barely see.

That gap matters. The challenges of injectable treatment are not always about the medicine itself. Practical concerns also matter, from knowing where to inject and worrying about pain to storing a pen correctly or managing a missed dose while travelling.

This page is about the hardware and the technique. Doses are not covered, because those come from your prescriber and the patient information leaflet supplied with your medicine.

Key things to know

• GLP-1 injections go into the fat layer just under the skin, not into muscle or a vein.
• Pen needles are generally short and fine, although the level of discomfort varies from person to person and between devices.
• Rotating the injection site matters, because repeatedly using the same spot can change how the medicine is absorbed.
• These medicines have specific storage limits. Do not use a pen that has been frozen, and seek advice from your pharmacist if it has been exposed to temperatures outside the limits in its product leaflet.
• All GLP-1 medicines are prescription only, and the MHRA is clear they can only be prescribed by a healthcare professional.

What a GLP-1 injection is

It is a subcutaneous injection, meaning it goes into the fat layer just beneath the skin rather than into muscle or a blood vessel. That layer has a good blood supply but far fewer pain receptors than the skin surface, which is central to why these injections feel the way they do.

The medicine is a peptide, a short chain of amino acids built to resemble a naturally occurring hormone your gut releases after eating. The MHRA describes GLP-1 medicines as helping people feel fuller by mimicking a natural hormone released after eating. These glp 1 agonists support weight loss by slowing digestion, lowering blood sugar levels, and improving blood sugar control. GLP-1 receptor agonists help regulate appetite and blood glucose. Depending on the medicine and brand, they may be prescribed for type 2 diabetes or weight management, alongside appropriate lifestyle measures. Their authorised uses and eligibility criteria differ, so treatment should be based on an individual clinical assessment.

GLP-1 medications are prescription-only and must be prescribed by a healthcare professional. The healthcare team assesses eligibility criteria, including body mass index (BMI) and the presence of specific medical disorders such as obstructive sleep apnoea and kidney disease. These medicines are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA), which assesses their quality, safety and effectiveness for authorised uses. They can still cause side effects and require appropriate prescribing and monitoring.

How do GLP-1 injections work?

Three effects, working together rather than separately.

They act on appetite signalling in the brain, reducing hunger and the pull towards food between meals. They slow how quickly the stomach empties, so a meal produces fullness that lasts longer. And they increase insulin release in response to eating while reducing glucagon, which is why the class came out of diabetes medicine before its weight effects were licensed.

The route of delivery does not change any of that. Injecting is simply how the molecule gets into circulation intact.

Why are they injected rather than swallowed?

Peptide medicines can be difficult to deliver by mouth because digestive enzymes may break them down and the gut may absorb them poorly. Many GLP-1 medicines are therefore given by injection. Oral formulations also exist, but they require specific formulations and administration instructions.

Injecting under the skin bypasses that. It is not a preference or a marketing decision, it is the straightforward solution to a chemistry problem. Oral versions do exist in this class, but they need a specialised formulation and come with strict rules about food and timing as a result.

If injecting is the part putting you off, it is worth seeing which prescription weight loss injections are licensed here, and what the alternatives involve, before deciding. Treatment suitability depends on an individual clinical assessment.

The pen itself

How a pre-filled pen works

A pre-filled pen is a self-contained device holding the medicine in a sealed cartridge. You attach a fresh needle, set or confirm the dose according to your pen's instructions, place it against the skin and press the button. A spring or plunger mechanism delivers a measured amount.

The pen is designed to deliver a measured dose, but the preparation and injection steps depend on the device. Some pens have preset doses, while others require the user to select the prescribed dose. Follow the instructions for your specific pen rather than assuming all devices work in the same way.

Single dose and multi dose pens

Pens come in two broad designs. Some are used once and disposed of. Others hold several doses in one cartridge and are used over a period of weeks before being discarded.

Which type you have changes the practicalities: how often you attach a new needle, how the pen is stored between uses, and how long it can be kept once started. Your patient information leaflet is the authority on which it applies to you.

GLP-1 needle size explained

Pen needles are described by two numbers, and understanding them removes most of the fear.

The first is gauge, written as a number followed by G. Counterintuitively, a higher gauge number means a thinner needle. Pen needles sit at the very thin end of the range, considerably finer than the needles used to take blood.

The second is length, in millimetres. Pen needles are short, designed to reach the fat layer just under the skin and go no further. They are a fraction of the length of the needles most people picture when they imagine an injection.

Together those two properties explain why the experience is so different from a vaccination or a blood test. Always use the needle type specified for your pen, and always use a new one for each injection.

Weekly versus daily GLP-1 injections

Some medicines in this class are injected once a week, others once a day. The difference is engineering rather than strength.

Neither pattern is the right one in general. Which medicine you are prescribed depends on your assessment rather than on which schedule you would prefer, though it is reasonable to raise your preference.

Where to inject a GLP-1

Three sites are used, all chosen because they have a reliable fat layer just under the skin.

The three injection sites

• The abdomen, avoiding the area immediately around the navel. This is the site most people use most often.
• The front or outer thigh, in the fleshy part rather than near the knee or hip.
• The back of the upper arm, which many people find awkward to reach themselves.

Avoid injecting into skin that is bruised, tender, hard, lumpy, scarred, reddened or broken. Follow your pen's instructions for selecting and preparing an appropriate injection site.

Why rotating the site matters

This is the part most often skipped and the part with the clearest consequence. Injecting repeatedly into the same small area can cause the fatty tissue there to change, becoming firmer or lumpy over time.

That matters beyond appearance. Tissue that has changed in this way can absorb medicine differently and less predictably, which means an injection into a well used spot may not behave the same as one into fresh tissue. Rotating protects the consistency of your treatment, not just your comfort.

A simple system works: move around a site in a pattern rather than at random, and change site periodically. Some people keep a note on their phone alongside their injection day reminder.

How to use a GLP-1 pen

The instructions for your specific pen are in the patient information leaflet, and you should be shown how to use it before your first injection. What follows is the general sequence, which is broadly consistent across devices.

1. Check the pen. Confirm it is the right medicine, that it is on date, and that the liquid looks as the leaflet describes.
2. Check whether your pen's instructions recommend allowing it to reach room temperature before injection. If so, follow the stated guidance and never heat the pen artificially.
3. Wash your hands and attach a new needle.
4. Prime or perform the flow check if your pen requires it, exactly as the leaflet sets out.
5. Choose and clean the site, then let the skin dry.
6. Inject according to your pen's instructions, holding it in place for the stated count so the full dose is delivered.
7. Remove and dispose of the needle safely in a sharps bin.

What commonly goes wrong

• Removing the pen too soon, before the full dose has been delivered. Hold for the count your leaflet specifies.
• Use a new needle for each injection if your pen requires an attachable needle. Reusing needles can compromise hygiene and may increase the risk of needle damage, blockage or injection problems.
• Cold medicine may contribute to discomfort for some people. Follow your product's instructions about temperature before injecting, and ask your pharmacist for advice if injections repeatedly sting.
• Using the same spot repeatedly, for the reasons above.
• Rubbing the area afterwards. Light pressure with a clean tissue is enough.

Does the GLP-1 injection hurt?

Most people find it far less painful than expected, and many describe feeling almost nothing. That is not reassurance, it is a consequence of the design.

Why it hurts less than people expect

Three reasons. Pen needles are generally short and fine, which may make injections less uncomfortable than people expect. However, pain varies between individuals, and some people experience stinging, tenderness or bruising.

The comparison people have in mind is usually a vaccination, which goes into muscle with a longer needle, or a blood test, which uses a wider needle into a vein. Neither is a fair comparison.

What to do if it stings

Usually the liquid rather than the needle is responsible, and the fix is temperature. Take the pen out of the fridge well before you use it and let it come to room temperature.

Other things that help: use a new needle every time, let the skin dry fully if you have cleaned it, do not tense the area, and go in with a decisive movement rather than a hesitant one. If a particular site consistently hurts more, use a different one.

A small bruise afterwards is common and simply means the needle passed through a tiny blood vessel. It is not a sign anything went wrong.

For anyone who finds needles genuinely difficult rather than mildly unpleasant, GLP-1 tablet treatment is a legitimate option to raise at your assessment rather than something to push through.

How to store GLP-1 pens

These medicines are peptides, which makes them sensitive to both heat and freezing. Storage is not a minor housekeeping detail; it affects whether the medicine still works.

Before first use

Before first use, store the pen according to the temperature range and other instructions in its patient information leaflet. Keep it away from the freezer compartment and do not allow it to freeze.

Once a pen is in use

In-use storage rules are usually different and often more relaxed, with a maximum period the pen can be kept once started. Your leaflet gives both the temperature range and the time limit, and both matter.

Travelling with a pen

When flying, keep your medicine in hand luggage where possible, protect it from extreme temperatures and follow the product's storage instructions. If you use an insulated pouch, do not let the pen come into direct contact with ice packs. Carry the prescription or pharmacy label and check the airline's requirements for medical supplies and sharps.

When a pen should not be used

Do not use a pen that has been frozen or is outside its expiry date or permitted in-use period. If it has been exposed to excessive heat or you are unsure whether it remains usable, contact the supplying pharmacy before using it.

Missed dose

What to do after a missed dose depends on the specific GLP-1 medicine and how long it has been since the scheduled injection. Follow your medicine's patient information leaflet and do not take an extra dose to compensate unless a healthcare professional specifically instructs you to do so. If you have missed multiple doses, contact your prescribing service before restarting.

GLP-1 injection side effects

Common side effects

Mostly gastrointestinal. The MHRA notes that gastrointestinal side effects may affect more than one in ten patients, with nausea, vomiting and diarrhoea among the most common. Constipation, indigestion, burping, reduced appetite and tiredness are also frequently reported.

These are usually most noticeable when treatment starts and after each dose change, and they commonly ease as the body adapts.

Less common but serious

The MHRA asks prescribers to discuss less common but serious risks including pancreatitis and gall bladder disorders. Less common but serious risks include pancreatitis and gallbladder disorders. Severe or persistent abdominal pain, particularly if it spreads to the back or occurs with vomiting, requires urgent medical assessment.

A very rare eye condition called non-arteritic anterior ischaemic optic neuropathy (NAION) has been linked to semaglutide. Anyone taking semaglutide who experiences sudden vision loss or rapidly worsening eyesight should seek urgent medical assessment. Low blood glucose is also a concern when certain GLP-1 medicines are used with insulin or sulfonylureas.

Injection site reactions

Redness, mild itching, a small lump or slight tenderness at the site are common and usually settle within a few days. Rotation, a new needle each time and a room temperature pen all reduce them.

Contact a healthcare professional if the area becomes hot, increasingly painful or swollen, if redness spreads, if there is pus or discharge, or if you develop a fever. Signs of an allergic reaction such as a widespread rash, swelling of the face, lips or throat, or difficulty breathing need emergency care.

Suspected side effects can be reported through the MHRA Yellow Card scheme, and you do not need to be certain the medicine caused the problem.

Sharps disposal

Dispose of used needles and injection devices according to the instructions supplied with your medicine and your local arrangements. Use an appropriate sharps container where required, never place loose needles in household waste or recycling, and ask your pharmacy or local council about safe disposal.

Getting treatment safely

Every GLP-1 medicine is prescription only, so a legitimate supply always begins with an assessment. The MHRA is explicit that these medicines should not be bought from unregulated sellers such as beauty salons or via social media, or from anywhere without a prior consultation with a healthcare professional.

A legitimate UK service should arrange an appropriate clinical assessment before prescribing, review relevant medical history and eligibility, and supply the medicine through a properly registered pharmacy. Patients should receive the relevant product information and know how to contact their prescriber if problems arise.

The medicine is one part of the picture. NICE positions weight management medicines as something used alongside a reduced calorie diet and increased physical activity rather than instead of them, and structured weight loss help is what decides how much of the result you keep.

Medical Disclaimer

This article is general information about prescription only medicines and the devices used to give them, and is not medical advice. It contains no dosing instructions and no dose escalation schedule, and it is not a substitute for a consultation with a qualified healthcare professional or for the training you should receive before your first injection. These medicines should only be used under the supervision of an appropriately qualified prescriber and in line with the approved patient information leaflet supplied with your medicine.

Treatment suitability depends on an individual clinical assessment, and results vary between individuals. Seek urgent medical attention for severe or persistent abdominal pain, repeated vomiting, sudden changes in vision, spreading redness or fever at an injection site, or signs of an allergic reaction such as swelling of the face, lips or throat or difficulty breathing. Suspected side effects can be reported through the MHRA Yellow Card scheme.